To validate the clinical relevance of our findings, we first used The Cancer Genome Atlas (TCGA) transcriptomics microarray data of 538 chemo-naïve OC samples to assess survival associations of COL6, FN1, and VTN expression. This evidence concerns the gene FN1 and cancer.